Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 6, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Scientific, Technical Research and Project Management Support Services for USAMRIID

Closed
HT942525R0005Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541714
New
Grant
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Solicitation # RFA-AI-28-012
The National Institute of Allergy and Infectious Diseases (NIAID) has issued solicitation RFA-AI-28-012 to establish a consortium of Translational Centers Using Microphysiological Systems for Infectious Diseases (TCMID). The primary objective is to refine and validate human tissue models using Microphysiological Systems (MPS) to a level consistent with regulatory qualifications, thereby promoting their adoption by product developers and reducing reliance on laboratory animals. This initiative aligns with NIH and FDA guidance on New Approach Methodologies (NAMs) to accelerate the development of safer medical interventions by capturing human variability and patient-specific characteristics. The program is structured around an Administrative Core, a Qualification Core, and Scientific Cores, with a heavy emphasis on technical readiness, reproducibility, and regulatory acceptance. Key deliverables include the validation of assays for specific endpoints and the submission of regulatory packages. Applicants must be domestic entities, as foreign organizations and foreign subawards are strictly prohibited. Required personnel must possess deep expertise in infectious diseases, MPS platforms, bioinformatics, and FDA submission processes. Applications are due by January 29, 2027, and must be submitted via the NIH ASSIST system or approved institutional system-to-system solutions. Evaluation is based on an overall impact score considering the project's significance, the suitability of the investigators, and the quality of the institutional environment. Mandatory application components include a Data Management and Sharing Plan and a Benchmarks and Timeline PDF not exceeding six pages. Awardees must also adhere to strict cybersecurity incident reporting guidelines, notifying HHS within 48 hours of any discovery.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in 3 months
NAICS: 541714
New
Grant
Immune Tolerance Network (UM1 Clinical Trial Required)
Solicitation # RFA-AI-28-005
The National Institutes of Health, under the Department of Health and Human Services, is seeking applications through solicitation RFA-AI-28-005 to continue the Immune Tolerance Network (ITN). This cooperative agreement aims to develop tolerogenic therapies for immune-mediated disorders, specifically focusing on autoimmune diseases, allergic diseases and asthma, and the immune-mediated consequences of transplantation. The network operates through four integrated functional areas: Leadership, Clinical Operations, Core Laboratory, and Bioinformatics. Its primary objectives include designing and conducting clinical trials, performing integrated mechanistic studies, and sharing research results. Eligible applicants include small businesses and other for-profit organizations, though non-domestic entities are ineligible. Applications are evaluated based on scientific and technical merit, with a primary focus on significance and the likelihood of exerting a sustained influence on the research field. Key requirements include maintaining active registrations in SAM.gov, eRA Commons, and Grants.gov, as well as adhering to strict cybersecurity incident reporting and human subject protection protocols. The project requires a minimum effort of 3.6 person months per year for the PD/PI and mandates participation in a kick-off meeting in Bethesda, Maryland, and bi-annual steering meetings. Applications must follow specific page limits for the research strategy subsections and include detailed plans for clinical trial implementation, data management, and biorepository services.
National Institutes Of Health

POSTED

about 24 hours ago

DEADLINE

in 3 months
NAICS: 541714
New
Federal
Pre-Award Synopsis Texas Shield
Solicitation # DARPA-SN-27-07
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), intends to enter into an agreement with The University of Texas System consortium of universities for the Texas Shield Program. This integrated research initiative, identified by solicitation number DARPA-SN-27-07 and NAICS code 541714, focuses on developing autonomous and semi-autonomous medical technologies and scalable solutions for critical medical consumables. The primary goal is to support lifesaving medical care in contested, austere, and resource-limited environments. Key technical areas of focus include autonomous medical and robotic surgical systems, casualty evacuation, artificial-blood and supply innovation, AI-enabled clinical decision support, and mass-casualty science and simulation. This notice is a pre-award synopsis and is not a request for proposals or a competitive solicitation. Interested entities are invited to submit information by November 15, 2026, to TexasShieldxBTO@darpa.mil detailing their technical expertise, integrated research infrastructure, clinical-validation capabilities, and multi-institutional coordination capacity. Additionally, respondents must describe their consortium organizational structure, commercialization capabilities, facility clearance levels, and their ability to handle Controlled Unclassified Information. The government will not reimburse any costs associated with the preparation or submission of information in response to this notice.
Defense Advanced Research Projects Agcy

POSTED

5 days ago

DEADLINE

in 25 days
NAICS: 541714
New
Federal
Q--AMPLICON SEQUENCING SERVICES
Solicitation # 140G0226Q0047
Solicitation 140G0226Q0047 is a firm-fixed-price request for a Blanket Purchase Agreement (BPA) to provide next generation amplicon sequencing services for the USGS Upper Midwest Water Science Center’s Michigan Bacteriological Research Laboratory. The scope of work includes providing all equipment, labor, travel, and materials necessary to support research on bacterial pathogens, harmful algal blooms, microbial ecology, antibiotic resistance, and microbial source tracking. Key technical requirements include the use of Illumina MiSeq or AVITI sequencing technologies and the potential for library preparation for 16S V4 amplicon sequencing. The BPA has a total not-to-exceed value of 250,000 dollars with an estimated period of performance from September 17, 2026, to September 16, 2031. The award process prioritizes non-priced factors significantly over cost, focusing on the offeror's qualifications and technical performance. Evaluation criteria include a detailed listing of on-site equipment and calibration dates, personnel experience, internal quality assurance procedures, and a technical narrative not exceeding two pages. Performance will be executed in Lansing, Michigan, with delivery terms set as FOB Destination. Administrative requirements include electronic invoicing via the Internet Payment Platform and compliance with various federal regulations, including the Buy American Act and specific security prohibitions regarding telecommunications equipment. Proposals must be submitted to the USGS OAG Denver Acquisition Branch by September 11, 2026.
Ofc Of Acquisition Grants-Denver

POSTED

5 days ago

DEADLINE

in 3 days

AI Contract Overview

Show more

The contract pertains to providing comprehensive scientific, technical, and project management support services to the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at Fort Detrick, Maryland. The scope includes supporting a wide range of biological research activities across biosafety levels 2 through 4, including bacterial pathogenesis, immunology, vaccine development, molecular biology, aerobiology, and diagnostic testing. The contractor must possess expertise in maintaining and operating high-containment laboratories, ensuring compliance with FDA Good Laboratory Practices, CFR regulations, and international standards. Key responsibilities involve conducting research, supporting technology development, maintaining laboratory equipment, managing data, and providing specialized personnel capable of supporting regulatory activities, animal research, and advanced diagnostics. The contract emphasizes the importance of personnel qualified in biosafety, bioinformatics, and regulatory compliance, with a focus on developing medical countermeasures such as vaccines and therapeutics. The solicitation, issued under an 8(a) set-aside, remains open until May 22, 2025, with detailed instructions for proposal submission available on SAM.gov.

General Info

Contract for 8(a) small businesses providing scientific and technical support to USAMRIID at Fort Detrick.

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Frederick, MD, 21702, USA

Set-Aside

8A

Documents

23

Attachment 02 - Quality Assurance Surveillance Plan (QASP)

DOCX, High priority: read this first10 pages · qasp
High

Attachment 05 - Historical LOE, Key Personnel and BPRP/CS-PRP Requirement

PDF, High priority: read this firstspecifications
High

Attachment 07 - List of GFP (HT9425-25-R-0005)

XLSX, High priority: read this first8 pages · gfp-list
High

Attachment 11 - BPRP Factors to Consider

PDF, High priority: read this firstspecifications
High

Attachment 12 - OCI Certification

DOCX, High priority: read this first3 pages · oci-certification
High

DD Form 254 - Contract Security Classification Specification (HT942525R0005)

PDF, High priority: read this firstspecifications
High

HT942525R0005 Amendment 0001

DOCX, High priority: read this first15 pages · amendment
High

HT942525R0005 Amendment 0001 Attachment 02 - Quality Assurance Surveillance Plan

DOCX, High priority: read this first10 pages · qasp
High

HT942525R0005 Amendment 0002

DOCX, High priority: read this first2 pages · amendment
High

HT942525R0005 Attachment 04 - Labor Categories and Descriptions

PDF, High priority: read this first11 pages · specifications
High

HT942525R0005 Attachment 14 - Pricing Sheet

XLSX, High priority: read this first7 pages · specifications
High

HT942525R0005 Attachment 14 - Supplemental Cost/Price Worksheet

XLSX, High priority: read this first7 pages · specifications
High

HT942525R0005 Science Support Services - Offerors Questions and Answers

PDF, High priority: read this first10 pages · q-and-a
High

USAMRID Scientific, Technical and Project Management Support Services - Labor Categories and Descriptions

PDF, High priority: read this firstspecifications
High

USAMRIID Scientific, Technical and Project Management Support Services PWS

DOCX, High priority: read this first125 pages · sow
High

USAMRIID Scientific, Technical and Project Management Support Services PWS

DOCX, High priority: read this first125 pages · sow
High

Wage Determination No. 2015-4269 (Rev 28)

PDF, High priority: read this firstwage-determination
High

Attachment 03 - Non-Disclosure Statement

DOCX, Low priority1 page · nda
Low

Attachment 13 - Performance Assessment Questionnaire

DOCX, Low priority3 pages · past-performance
Low

DA Form 3180-1: Chemical and Biological Personnel Reliability Program Statement of Understanding

PDF, Low priorityother
Low

DA Form 3180-2: Chemical and Biological Personnel Screening and Evaluation Record

PDF, Low priorityother
Low

DA Form 7708 - Personnel Reliability Screening and Evaluation

PDF, Low priority2 pages · other
Low

HT942525R0005 Science Support Services

DOCX, Low priority49 pages · other
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

4 updates
PhaseClosed
Posted

Presolicitation

Notice updated

The notice description changed.

Notice updated

Response deadline changed from Apr 3, 2025 to May 1, 2025. The notice description changed.

Type Changed

Presolicitation → Solicitation

Notice updated

Response deadline changed from May 5, 2025 to May 22, 2025. The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Army Medical Resources Acq Activity
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Christina Lewis
Jayme Fletcher

Full Description

Show more
AMENDMENT 0002 - The purpose of Amendment 0002 is to provide a response to an additional question received in resposne to the solicitation. The closing date remains unchanged. No additional questions will be accepted. Please refer to HT942525R0005 Amend 0002 for additional information. ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- AMENDMENT 0001 - The purpose of Amendment 0001 is to provide answers to questions recieved from potential Offerors and revise attachments accordingly. The closing date specified in the original RFP is being extended to 22 May 2025 as a result of Amendment 0001. Please refer to HT942525R0005 Amend 0001 for additional information. ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- The requirement is for non-personal, scientific, technical and project management Contractor support services in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) required to accomplish their mission of protecting the Warfighter from biological threats, being prepared to investigate disease outbreaks or threats to public health and providing leading edge medical capabilities to deter and defend against current and emerging biological threat agents. Specifically, USAMRIID's Bacteriology, Molecular Biology, Virology, Diagnostic Systems, Aerobiology, Animal Clinical Pathology, Telemetry, Medicine, Pathology, Regulated Research Administration and Risk Management Divisions have a need for scientific and technical support services necessary to execute funded projects to help meet the USAMRIID mission. The contractor should have knowledge of the Army's Biological Personnel Reliability Program (BPRP) and the Controlled Substance Personnel Reliability Program (CS-PRP), and knowledge and capabilities to provide Scientific, Technical Research and Program Management Support Services for USAMRIID, including in Biosafety Level (BSL)-2 through BSL-4 biocontainment laboratories, at Fort Detrick, Maryland. Some of the support services includes but are not limited to: - Providing research support. - Providing technical support for technology development and evaluation, and animal research protocols. - Providing equipment maintenance and validation for Food and Drug Administration (FDA) Good Laboratory Practices (GLP) compliance. - Performing clinical pathology sample evaluation and reporting of data. - Organizing study rooms with necessary equipment. - Maintaining a current inventory of telemetry implants. - Configure telemetry hardware and software for data acquisition. - Providing administrative and technical guidance with medical background. - Working in conjunction with the various sciences divisions to project and identify research needs, develop, and coordinate study protocols, and execute approved research projects. - Providing scientific and technical support necessary to execute all aspects of the sciences divisions and USAMRIID's current missions. - Providing FDA GLP expertise. - Maintaining all laboratory equipment and supplies. - Developing new ultrastructural and molecular pathology techniques. - Providing necropsy support in Biosafety Level (BSL)-2 through BSL-4 biocontainment laboratories. - Being responsible for the overall performance of high complexity clinical and general laboratory testing in BSL-2 through BSL-4 biocontainment laboratories. - Providing expertise in bacterial pathogenesis, immunology, vaccines, and therapeutics. - Establishing research protocols and providing research governance of data integrity and good research conduct. - Providing expertise in high-level bioinformatics for integration and analysis of approximately four Terabytes of data produced monthly. - Providing technical support services to include laboratory procedures supporting sample processing with management of standard operating procedures and maintaining compliance with USAMRIID Safety regulations. - Providing personnel with qualifications to support all mission requirements including co-principal investigators, staff scientists, and technicians. - Providing support to conduct viral pathogenesis research, viral biology research, viral immunology research, animal modeling, cell biology, viral molecular biology, and vector assessment. - Providing personnel with qualification to meet regulatory and accredited activities under applicable parts of Code of Federal Regulations (CFR) Title 21 (21 CFR) Good Laboratory Practices/Current Good Manufacturing Practices, 42 CFR Clinical Laboratory Improvement Program/Clinical Laboratory Improvement Amendments, International Organization for Standardization standards and accreditation agency guidelines as applicable. - Providing support to conduct aerobiology research in BSL-3 and BSL-4 biocontainment and engineering support to maintain, calibrate and certify aerosol equipment. - Providing personnel that will be expected to support and execute research, repository, reagent production, verification/validation, and diagnostic and service support in BSL-2 through BSL-4 biocontainment laboratories. - Providing personnel capable of conducting immunodiagnostic research, molecular diagnostic research, and advanced development of diagnostics to support regulatory approval. - Provide personnel capable of using their knowledge and experience of best pharmaceutical industry practices related to development of medical countermeasures, such as vaccines, therapeutics, and diagnostics, to develop an integrated program. This includes establishment of the tools and models required to conduct nonclinical studies of product candidates. - Provide technical and program management suite supervision support for BSL-2 through BSL-4 biocontainment suites. Refer to the attached solicitation for additional details. All questions and proposals shall be submitted as outlined in Section L, Instructions to Offerors, of the solicitation.

More opportunities from Department Of Defense → Army Medical Resources Acq Activity

Same awarding agency

NAICS: 813920
New
Federal
Biomedical Research Application Evaluation and Support (BRAES)
Solicitation # HT942727RE006
The Biomedical Research Application Evaluation and Support (BRAES) contract is a performance-based, non-commercial Multiple Award Indefinite Delivery Indefinite Quantity (MA-IDIQ) solicitation issued by the Defense Health Agency for the Congressionally Directed Medical Research Programs. With a ceiling cost of 137 million dollars and an estimated period of performance from January 2027 to January 2032, the contract supports the evaluation of biomedical research applications. The scope is divided into four primary areas: funding opportunity announcement set-up, oversight of application receipt and processing, application compliance review, and scientific merit peer review. While the first three tasks are awarded to a single vendor via the eBRAP task order, the scientific peer review tasks are awarded to multiple vendors through Science Administration and Management (SAM) task orders, which require the operation of a secure, contractor-owned, contractor-operated (COCO) web-based system. The government will utilize a Highest Technically Rated with a Fair and Reasonable Cost/Price approach to select approximately three awardees. Evaluation factors include technical approach, management approach, past performance, and small business participation, with cost and price serving as the final check for the highest-rated proposals. Key requirements for offerors include an active SAM registration, a CMMC Level 1 self-assessment, and the submission of a five-volume proposal by December 2, 2026. Contract administration involves a mix of Cost Plus Fixed Fee and Firm Fixed Price arrangements, with invoicing processed through the Wide Area Workflow system. Performance is monitored via Quality Assurance Surveillance Plans using random sampling and 100 percent inspection to determine CPARS ratings based on accuracy and schedule adherence.
Professional Organizations

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541715
New
Federal
Mild Traumatic Brain Injury (mTBI) Blast Injury Prevention Standards Request for Information
Solicitation # CB4_SW_mTBI_RFI
The Army Medical Resources Acq Activity, specifically the USAMRDC and the Department of War Blast Injury Research Coordinating Office in collaboration with The MITRE Corporation, has issued a Request for Information regarding Mild Traumatic Brain Injury blast injury prevention standards. This initiative aims to identify existing and emerging injury criteria, thresholds, standards, and models to inform the Military Health System Blast Injury Prevention Standards Recommendation process. The primary goal is to gather biomedically valid data, such as dose response curves and injury thresholds, to improve health hazard assessments, survivability assessments, and the development of protection systems for service members exposed to explosive weapons. This notice is issued solely for information and program planning purposes and does not constitute a formal solicitation for proposals. In accordance with FAR 15.201(e), responses are not considered offers and cannot be accepted to form a binding contract, nor will the government provide reimbursement for costs associated with participating. Interested parties from industry, academia, and other federal agencies are encouraged to submit relevant publications, reports, and images through a specific online submission process. The primary point of contact for this effort is Contract Specialist Skylar Wells, and the response deadline is November 3, 2026.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 days ago

DEADLINE

in 13 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS